MicroPort CardioFlow is based in Shanghai, China. It has raised $132M in total funding. Latest round: Series C.
MicroPort CardioFlow is based in Shanghai, China. MicroPort CardioFlow has raised $132M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in April 2020. The round record for MicroPort CardioFlow runs through 2020; nothing later has been disclosed. Investors on record include CPE, Hillhouse Capital Management, Ltd., Lake Bleu Capital, Gamnat, China Reform Conson Soochow Overseas Fund I L.P., Gortune Artemis Limited and 1 others. 7 distinct backers are named across the disclosed rounds.
We update the MicroPort CardioFlow record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Shanghai and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026